Positive Opinion on Roche’s Avastin – Analyst Blog

By | September 24, 2012
0 Comment

The Committee for Medicinal Products for Human Use (CHMP)recently provided a positive opinion on the use of Roche Holdings Ltd. ‘s ( RHHBY ) Avastin (bevacizumab) plus chemotherapy

View article:
Positive Opinion on Roche’s Avastin – Analyst Blog

Related posts:

  1. CHMP Positive on Novartis Drugs – Analyst Blog
  2. Data from Roche’s Perjeta Study – Analyst Blog
  3. Roche’s Tamiflu Label Expanded – Analyst Blog
  4. Roche Oncology Candidate Progresses – Analyst Blog